Abstract: A liquid leakage detection apparatus configured for liquid leakage detection of a liquid cooling apparatus of a printed circuit board, wherein the liquid leakage detection apparatus includes a sleeve, a first liquid cooling pipe, a liquid cooling plate, flow guiding apparatuses, and a liquid leakage detection circuit. The sleeve wraps the first liquid cooling pipe, the first liquid cooling pipe is coupled to the liquid cooling plate, the liquid cooling plate and the first liquid cooling pipe are configured to dissipate heat for an electronic element using a filled coolant, the flow guiding apparatuses are coupled to an edge of the liquid cooling plate, the other ends of the flow guiding apparatuses are coupled to the liquid leakage detection circuit.

Abstract: The subject invention relates to two-stage inoculation and two-stage fermentation process which are performed by the inoculation time difference and staged fermentation. In the first stage, yeast, lactic acid bacteria and Acetobacter aceti are inoculated into a fermentation tank to perform primary fermentation to produce primary fermented material. In the second stage, yeast is added into the primary fermented material in a container to perform the secondary fermentation to produce secondary fermented material, and then the secondary fermented material is pasteurized to deactivate yeast, lactic acid bacteria and Acetobacter aceti in the container and stop fermentation reaction. Finally, the secondary fermented material is cooled to ambient temperature to prepare the kombucha fermented beverage preserving active fermentative bacteria and enzyme at ambient temperature. The invention is help to improve the preservation convenience of the kombucha fermented beverage and avoid excessive alcohol concentration.

Abstract: The present invention provides novel artificial tears containing a recombinant human lysozyme. The novel artificial tears comprise main components and an auxiliary material. The main components are a recombinant human lysozyme and a sodium hyaluronate, wherein the recombinant human lysozyme and the sodium hyaluronate are contained in an amount from 0.075%-0.300% and from 0.10%-0.30%, respectively in the total mass of the novel artificial tears. A drug for external use is prepared by combining the recombinant human lysozyme, the sodium hyaluronate and an excipient for treating light and moderate dry eye syndrome.

Abstract: The present invention provides novel artificial tears containing a recombinant human lysozyme and a recombinant human epidermal growth factor. The novel artificial tears comprise main components and an auxiliary material. The main components are a recombinant human lysozyme, a recombinant human epidermal growth factor, and sodium hyaluronate, wherein the recombinant human lysozyme, the recombinant human epidermal growth factor, and sodium hyaluronate are contained in an amount from 0.075% to 0.300%, from 0.002% to 0.004%, and from 0.10% to 0.30%, respectively in the total mass of the novel artificial tears.

Abstract: A spindle lock (10) includes a detent arrangement including springs (25) acting on projections (30), each projection engaging one of a pair of recesses (40, 41) to control and buffer the rotation of a spindle (13) and to delay the engagement of locking elements (26a, 26b). A compact, reliable mechanism with a high degree of modularity is achieved by providing the recesses in an inner rotor (31) and the springs and projections in an outer rotor (18) that extends about the inner rotor.

Abstract: A spindle lock (10) includes a detent arrangement including springs (25) acting on projections (30), each projection engaging one of a pair of recesses (40, 41) to control and buffer the rotation of a spindle (13) and to delay the engagement of locking elements (26a, 26b). A compact, reliable mechanism with a high degree of modularity is achieved by providing the recesses in an inner rotor (31) and the springs and projections in an outer rotor (18) that extends about the inner rotor.